sulfasalazine has been researched along with EBV Infections in 5 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present an unusual case of a patient with extreme lymphoplasmacytosis and hepatic failure in association with a reaction to sulfasalazine and a concurrent Epstein-Barr virus (EBV) infection." | 8.82 | Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature. ( Anastopoulos, HT; Ballesteros, E; Halmos, B; Schnipper, LE, 2004) |
| "We present an unusual case of a patient with extreme lymphoplasmacytosis and hepatic failure in association with a reaction to sulfasalazine and a concurrent Epstein-Barr virus (EBV) infection." | 4.82 | Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature. ( Anastopoulos, HT; Ballesteros, E; Halmos, B; Schnipper, LE, 2004) |
| "A 58-year-old woman with rheumatoid arthritis (RA) developed fever, skin eruptions, leukocytopenia, and thrombocytopenia, 3 weeks after treatment with sulfasalazine." | 3.74 | Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus. ( Hatakeyama, T; Komatsuda, A; Okamoto, Y; Sawada, K; Wakui, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Macaraeg, M | 1 |
| Schulert, GS | 1 |
| Sahm, J | 1 |
| de Groot, K | 1 |
| Schreiber, J | 1 |
| Halmos, B | 1 |
| Anastopoulos, HT | 1 |
| Schnipper, LE | 1 |
| Ballesteros, E | 1 |
| Takeyama, J | 1 |
| Umebayashi, H | 1 |
| Inagaki, T | 1 |
| Komatsuda, A | 1 |
| Okamoto, Y | 1 |
| Hatakeyama, T | 1 |
| Wakui, H | 1 |
| Sawada, K | 1 |
1 review available for sulfasalazine and EBV Infections
| Article | Year |
|---|---|
Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature.
Topics: Adult; Diagnosis, Differential; Drug Hypersensitivity; Epstein-Barr Virus Infections; Humans; Leukoc | 2004 |
4 other studies available for sulfasalazine and EBV Infections
| Article | Year |
|---|---|
Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.
Topics: Adult; Arthritis, Juvenile; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphohisti | 2023 |
Sulfasalazine-induced mononucleosis-like-illness and haemolysis.
Topics: Adult; Antirheumatic Agents; Drug Hypersensitivity Syndrome; Epstein-Barr Virus Infections; Female; | 2021 |
Renal involvement in a patient with juvenile idiopathic arthritis presenting after treatment for Hodgkin lymphoma.
Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Hematu | 2007 |
Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Hypersensitivity; Epstein-Barr Virus Infections; F | 2008 |